The effect of Gilbert's syndrome on the dispersions of QT interval and P-wave: An observational study;QT ve P dalga dispersiyonu üzerine Gilbert sendromunun etkisi: Gözlemsel bir çali{dotless}şma

Anadolu Kardiyoloji Dergisi

Volumn 13, Issue 6, 2013, Pages 559-565

  Cüre, Erkan ^a   Yüce, Süleyman ^a   Çiçek, Yüksel ^a   Cumhur Cüre, Medine ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Bilirubin; Gilbert's; Heart rate; P wave dispersion; QT dispersion

Indexed keywords

BILIRUBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECG ABNORMALITY; FEMALE; GILBERT DISEASE; HEART ARRHYTHMIA; HEART PROTECTION; HEART RATE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT CARE; P WAVE DISPERSION; QT DISPERSION; RISK REDUCTION; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; MIDDLE AGED; PHYSIOPATHOLOGY;

ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GILBERT DISEASE; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED;

EID: 84884800870     PISSN: None     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2013.180     Document Type: Article

References (43)

1. Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol 2003; 38: 107-17. [CrossRef]
2. Fertrin KY, Goncalves MS, Saad ST, Costa FF. Frequencies of UDPglucuronosyl transferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet 2002; 108: 117-9. [CrossRef]
3. Strassburg CP. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol 2010; 24: 555-71. [CrossRef]
4. Hirschfield GM, Alexander GJ. Gilbert's syndrome: an overview for clinical biochemists. Ann ClinBiochem 2006; 43: 340-3. [CrossRef]
5. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Rooij FJ, Lip GY, et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 2007; 167: 382-7. [CrossRef]
6. Cranefield PF, Wit AL, Hoffman BF. Genesis of cardiac arrhythmias. Circulation 1973; 47: 190-204. [CrossRef]
7. Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008; 198: 1-11. [CrossRef]
8. Tapan S, Karadurmuş N, Doǧru T, Ercin CN, Taşci{dotless} I, Bilgi C, et al. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem 2011; 44: 300-3. [CrossRef]
9. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 2008; 199: 390-6. [CrossRef]
10. Michelucci A, Bagliani G, Colella A, Pieragnoli P, Porciani MC, Gensini G, et al. P wave assessment: State of the art update. Card Electrophysiol Rev 2002; 6: 215-20. [CrossRef]
11. Magnani JW, Johnson VM, Sullivan LM, Lubitz SA, Schnabel RB, Ellinor PT, et al. P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol 2010; 15: 344-52. [CrossRef]
12. Ding LG, Hua W, Chu JM, Qiao Q, Chen KP, Wang FZ, et al. Improvement of P-wave dispersion is associated with a lower incidence of atrial fibrillation after cardiac resynchronization therapy. Chin Med J 2012; 125: 990-4.
13. Day CP, McComb JM, Campbell RW. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342. [CrossRef]
14. Bluzaite I, Brazdzionyte J, Zaliunas R, Rickli H, Ammann P. QT dispersion and heart rate variability in sudden death risk stratification in patients with ischemic heart disease. Medicina (Kaunas) 2006; 42: 450-4.
15. Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrology (Carlton) 2005; 10: 109-12. [CrossRef]
16. Coronel R, Fiolet JW, Wilms-Schopman FJ, Schaapherder AF, Johnson TA, Gettes LS, et al. Distribution of extracellular potassium and its relation to electrophysiological changes during acute myocardial ischemia in the isolated perfused porcine heart. Circulation 1988; 77: 1125-38. [CrossRef]
17. Michelucci A, Padeletti L, Frati M, Mininni S, Chelucci A, Stochino ML, et al. Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty. Pacing Clin Electrophysiol 1996; 19: 1905-8. [CrossRef]
18. Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician 2004; 69: 2599-606.
19. Osei-Bimpong A, Jury C, McLean R, Lewis SM. Point-of-care method for total white cell count: an evaluation of the HemoCue WBC device. Int J Lab Hematol 2009; 31: 657-64. [CrossRef]
20. Pac FA, Balli{dotless} S, Topaloǧlu S, Ece I, Oflaz MB. Analysis of maximum P-wave duration and dispersion after percutaneous closure of atrial septal defects: comparison of two septal occluders. Anadolu Kardiyol Derg 2012; 12: 249-54.
21. Paksoy F, Ulaş T, Tursun I, Dal MS, Oztekin E, Borlu F. The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study. Anadolu Kardiyol Derg 2012; 12: 16-22.
22. Nauman J, Janszky I, Vatten LJ, Wisloff U. Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA 2011; 306: 2579-87. [CrossRef]
23. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-94. [CrossRef]
24. Yi{dotless}ldi{dotless}ri{dotless}m N, Şimşek V, Tulmac M, Ebinc H, Doǧru MT, Alp C, et al. Atrial electromechanical coupling interval and p-wave dispersion in patients with white coat hypertension. Clin Exp Hypertens 2012; 34: 350-6. [CrossRef]
25. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733-8. [CrossRef]
26. Ishida K, Hayashi H, Miyamoto A, Sugimoto Y, Ito M, Murakami Y et al. P wave and the development of atrial fibrillation. Heart Rhythm 2010; 7: 289-94. [CrossRef]
27. Doǧan U, Doǧan EA, Tekinalp M, Tokgoz OS, Ari{dotless}baş A, Aki{dotless}lli{dotless} H, et al. P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci 2012; 9: 108-14. [CrossRef]
28. Dilaveris P, Stefanadis C. P-wave dispersion and atrial fibrillation risk: methodological considerations. Am J Cardiol 2011; 107: 1405. [CrossRef]
29. Dilaveris PE, Gialafos JE. P-wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 2001; 6: 159-65. [CrossRef]
30. Sari{dotless} I, Davutoǧlu V, Ozbala B, Ozer O, Baltaci{dotless} Y, Yavuz S, et al. Acute sleep deprivation is associated with increased electrocardiographic P-wave dispersion in healthy young men and women. Pacing Clin Electrophysiol 2008; 31: 438-42. [CrossRef]
31. Yi{dotless}ldi{dotless}z M, Pazarli{dotless} P, Semiz O, Kahyaoǧlu O, Sakar I, Alti{dotless}nkaynak S. Assessment of P-wave dispersion on 12-lead electrocardiography in students who exercise regularly. Pacing Clin Electrophysiol 2008; 31: 580-3. [CrossRef]
32. Pan KL, Hsu JT, Chang ST, Chung CM, Chen MC. Prognostic value of QT dispersion change following primary percutaneous coronary intervention in acute ST elevation myocardial infarction. Int Heart J 2011; 52: 207-11. [CrossRef]
33. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749-66. [CrossRef]
34. Macfarlane PW, McLaughlin SC, Rodger C. Influence of lead selection and population on automated measurement of QT dispersion. Circulation 1998; 98: 2160-7. [CrossRef]
35. Yang PC, Clancy CE. Effects of sex hormones on cardiac repolarization. J Cardiovasc Pharmacol 2010; 56: 123-9. [CrossRef]
36. Malkin CJ, Morris PD, Pugh PJ, English KM, Channer KS. Effect of testosterone therapy on QT dispersion in men with heart failure. Am J Cardiol 2003; 92: 1241-3. [CrossRef]
37. Zhou J, Tracy TS, Remmel RP. Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyl transferase 1A1 substrates/inhibitors. Drug Metab Dispos 2011; 39: 322-9. [CrossRef]
38. Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD et al. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos 2002; 30: 1266-73. [CrossRef]
39. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y et al. Hyperbilirubinemia, augmentation of endothelial function and decrease in oxidative stress in gilbert syndrome. Circulation 2012; 126: 598-603. [CrossRef]
40. Miyajima K, Minatoguchi S, Ito Y, Hukunishi M, Matsuno Y, Kakami M et al. The reduction of QTc dispersion by angiotensin II receptor blocker valsartan may be related to its antioxidative stress effect in patients with essential hypertension. Hypertens Res 2007; 30: 307-13. [CrossRef]
41. Matsuno Y, Minatoguchi S, Fujiwara H. GIFU Substudy Group of the Case-J Trial. Effects of candesartan versus amlodipine on homemeasured blood pressure, QT dispersion and left ventricular hypertrophy in high risk hypertensive patients. Blood Press Suppl 2011; 1: 12-9. [CrossRef]
42. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16: 250-5. [CrossRef]
43. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. ClinChem 1994; 40: 18-23.